HBIO

8.6600.23%
DP

David Panzarella

Senior Vice President of Commercial

Mr. David Panzarella is Senior Vice President of Commercial of Harvard Bioscience, Inc. from April 2026. Mr. Panzarella is a seasoned commercial executive with more than 30 years of leadership experience across life science tools, diagnostics, healthcare technology and advanced research platforms. He has built and scaled high-performing global commercial organizations spanning sales, marketing, field applications, service and strategic accounts, consistently driving profitable growth, operational rigor and customer-centric execution. David has extensive experience in small animal in vivo imaging, spatial biology, proteomics, genomics and advanced assay platforms. Over the course of his career, he has also helped lead organizations through pivotal value-creation milestones, including the Xenogen IPO, the Quanterix IPO and the aquisition of Caliper Life Sciences to PerkinElmer. Most recently, he served as Vice President and Commercial General Manager at Standard BioTools and prior to that held numerous senior commercial leadership roles at Nicoya Lifesciences, Magnetic Insight, Quanterix and PerkinElmer. He holds an M.B.A. in Finance with honors from Iona University and a B.S. in Business Administration and Marketing from Wright State University.

Positions